SCHEMBL3369565

SCHEMBL3369565

CCOC(=O)C(CCc1ccccc1)N1CCC[C@]1(C(=O)O)C(=O)[C@@H](N)CCCCNC(=O)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP8 Q6V1X1 4/20 0.38
DPP7 Q9UHL4 4/20 0.38
DPP9 Q86TI2 3/20 0.37
DPP4 P27487 2/20 0.37
ACE P12821 4/20 0.36
LMNA P02545 1/20 0.36
BACE1 P56817 1/20 0.35
TGM2 P21980 2/20 0.34
OPRD1 P41143 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ANPEP P15144 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6619629 1.00 DPP8 (0.38) DPP8DPP7DPP9DPP4ACE
SCHEMBL5551891 0.95 DPP8 (0.36) DPP8DPP7DPP9DPP4ACE
SCHEMBL3370863 0.90 DPP8 (0.37) DPP8DPP7DPP9DPP4ACE
SCHEMBL7275536 0.90 DPP8 (0.36) DPP8DPP7DPP9DPP4BACE1
SCHEMBL3373796 0.88 KMT2A (0.35) DPP8DPP7DPP9DPP4POLB
SCHEMBL10882100 0.85 DPP8 (0.40) DPP8DPP7DPP9DPP4ACE
SCHEMBL10885324 0.84 HPGD (0.36) DPP8DPP7DPP9DPP4ACE
SCHEMBL3372065 0.84 METAP2 (0.37) DPP8DPP7DPP9DPP4
SCHEMBL7266833 0.83 DPP8 (0.41) DPP8DPP7DPP9DPP4OPRD1
SCHEMBL10825128 0.82 ACE (0.39) ACELMNASMN1; SMN2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-8253497-A None JP disclosed
EP-1679303-B1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative KANEKA CORP (JP) 2010-09-15 EP disclosed
EP-1035131-B1 PROCESS FOR THE PREPARATION OF N2 -(1(S)-CARBOXY-3-PHENYLPROPYL)-L-LYSYL-L-PROLINE KANEKA CORP (JP) 2006-11-22 EP disclosed
EP-1513868-B1 PROCESS FOR THE PRODUCTION OF LISINOPRIL EOS ECZACIBASI OZGUN KIMYASAL (TR) 2006-08-09 EP disclosed
EP-1679303-A1 Process for preparing 1-alkoxycarbonyl-3-phenylpropyl derivative Kaneka Corporation (JP) 2006-07-12 EP disclosed
EP-0903337-B1 PROCESS FOR THE PREPARATION OF 1-ALKOXYCARBONYL-3-PHENYLPROPYL DERIVATIVES KANEKA CORP (JP) 2006-04-12 EP disclosed
EP-1035131-A1 PROCESS FOR THE PREPARATION OF N2 -(1(S)-CARBOXY-3-PHENYLPROPYL)-L-LYSYL-L-PROLINE KANEKA CORPORATION (JP) 2000-09-13 EP disclosed
EP-0903337-A1 PROCESS FOR THE PREPARATION OF 1-ALKOXYCARBONYL-3-PHENYLPROPYL DERIVATIVES KANEKA CORPORATION (JP) 1999-03-24 EP disclosed
JP-H08253497-A PEPTIDE-TYPE COMPOUND RICHTER GEDEON V G RT 1996-10-01 JP disclosed
EP-0336368-B1 N2-(1-carboxy-3-phenylpropyl)-L-lysine derivative and process of producing lysinopril using the compound KANEGAFUCHI CHEMICAL IND (JP) 1995-02-01 EP disclosed